ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,933Medicare Part D Prescriptions Filled, Including Refills

Rank: 683 out of 3593

$556K Total Retail Price of All Prescriptions

Rank: 522 out of 3593

461 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 461 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 461 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 7,452 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 542 493 1 1
LEVOTHYROXINE SODIUM 295 267 2 4
LISINOPRIL 263 242 3 2
CARVEDILOL 207 177 4 23
FUROSEMIDE 206 196 5 9
WARFARIN SODIUM 192 187 6 18
HYDROCHLOROTHIAZIDE 186 176 7 10
METFORMIN HCL 182 160 8 6
AMLODIPINE BESYLATE 158 139 9 3
ZOLPIDEM TARTRATE 153 128 10 12
OMEPRAZOLE 150 125 11 5
FENOFIBRATE 145 100 12 39
TRAMADOL HCL 132 118 13 17
HYDROCODONE-ACETAMINOPHEN 132 95 S3 13 7
METOPROLOL TARTRATE 123 106 15 8
ALLOPURINOL 108 106 16 35
NAMENDA 106 106 17 50
RAMIPRIL 103 90 18 92
LOSARTAN POTASSIUM 101 79 19 14
METOPROLOL SUCCINATE 101 91 19 19
SERTRALINE HCL 92 80 21 28
ATORVASTATIN CALCIUM 87 82 22 15
POTASSIUM CHLORIDE 86 79 23 24
PRAVASTATIN SODIUM 83 64 24 13
MELOXICAM 81 54 25 29
CLOPIDOGREL 78 69 26 30
DIGOXIN 77 77 27 58
GABAPENTIN 75 48 28 16
TAMSULOSIN HCL 74 65 29 33
CYCLOBENZAPRINE HCL 72 40 R 30 72
CITALOPRAM HBR 71 66 31 25
PLAVIX 70 64 32 42
ESCITALOPRAM OXALATE 68 63 33 71
CRESTOR 66 55 34 21
FLUTICASONE PROPIONATE 66 44 34 32
NIASPAN 63 60 36 186
PREDNISONE 62 56 37 49
OXYCODONE HCL-ACETAMINOPHEN 59 34 S2 38 82
ALENDRONATE SODIUM 56 52 39 22
PAROXETINE HCL 53 47 40 62
ATENOLOL 53 44 40 11
TRAZODONE HCL 53 35 40 53
CYMBALTA 52 32 43 73
DIOVAN 50 50 44 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.